Hikal Limited (NSE:HIKAL)

Market Cap	47.94B
Revenue (ttm)	18.65B
Net Income (ttm)	908.00M
Shares Out	n/a
EPS (ttm)	7.36
PE Ratio	52.80
Forward PE	34.44
Dividend	1.20 (0.31%)
Ex-Dividend Date	Feb 7, 2025

Volume	541,699
Average Volume	475,590
Open	395.45
Previous Close	392.40
Day's Range	386.10 - 396.75
52-Week Range	267.25 - 464.75
Beta	0.66
RSI	46.56
Earnings Date	May 9, 2025

About Hikal

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, wh...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Employees: 2,061
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: HIKAL

Financial Performance

In 2024, Hikal's revenue was 18.65 billion, an increase of 4.49% compared to the previous year's 17.85 billion. Earnings were 908.00 million, an increase of 30.46%.